Wave Life Company Insiders
| WVE Stock | USD 12.67 0.01 0.08% |
About 90 percent of Wave Life's insiders are activelly selling. The analysis of insiders' sentiment of trading Wave Life Sciences stock suggests that quite a large number of insiders are panicking at this time. Wave Life employs about 287 people. The company is managed by 16 executives with a total tenure of roughly 29 years, averaging almost 1.0 years of service per executive, having 17.94 employees per reported executive.
Insider Sentiment 10
Mostly Selling
Selling | Buying |
Latest Trades
| 2026-02-09 | Chandra Vargeese | Disposed 3228 @ 13.45 | View | ||
| 2026-01-02 | Chris Francis | Disposed 9375 @ 16.03 | View | ||
| 2025-12-11 | Plc Gsk | Acquired 1470000 @ 19 | View | ||
| 2025-12-09 | Kyle Moran | Disposed 50036 @ 20.03 | View | ||
| 2025-12-08 | Gregory L Verdine | Disposed 20000 @ 13.47 | View | ||
| 2025-11-13 | Adrian Rawcliffe | Disposed 16115 @ 6.79 | View | ||
| 2025-08-22 | Paul Bolno | Disposed 217351 @ 10.1 | View | ||
| 2025-08-13 | Christian O Henry | Disposed 9670 @ 8.81 | View | ||
| 2025-08-05 | Ken Takanashi | Disposed 4872 @ 8.75 | View | ||
| 2025-06-13 | Gregory L Verdine | Disposed 30000 @ 6.95 | View |
Monitoring Wave Life's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. Wave Life's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Wave Life's future performance. Based on our forecasts, it is anticipated that Wave will maintain a workforce of about 290 employees by March 2026.Wave Life Management Team Effectiveness
The company has Return on Asset of (0.2833) % which means that on every $100 spent on assets, it lost $0.2833. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.8651) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of February 16, 2026, Return On Tangible Assets is expected to decline to -0.26. In addition to that, Return On Capital Employed is expected to decline to -0.55. At present, Wave Life's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.66, whereas Other Assets are forecasted to decline to about 4.1 M.The current year's Common Stock Shares Outstanding is expected to grow to about 167 M, whereas Net Loss is forecasted to decline to (152.9 M). Wave Life Sciences retains a total of 185.76 Million outstanding shares. The majority of Wave Life outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Wave Life Sciences to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Wave Life Sciences. Please pay attention to any change in the institutional holdings of Wave Life Sciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 164 M | Current Value 167.7 M | Avarage Shares Outstanding 58.4 M | Quarterly Volatility 47.9 M |
Wave Life Workforce Comparison
Wave Life Sciences is rated second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,539. Wave Life retains roughly 287 in number of employees claiming about 19% of equities under Health Care industry.
The company has Net Profit Margin of (1.12) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (7.41) %, which entails that for every $100 of revenue, it lost $7.41. Wave Life Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Wave Life insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 1.2857 | 9 | 7 | 2,084,375 | 37,929 |
| 2025-12-01 | 0.5435 | 25 | 46 | 2,463,261 | 1,849,052 |
| 2025-09-01 | 2.4286 | 17 | 7 | 821,100 | 285,020 |
| 2025-03-01 | 1.75 | 14 | 8 | 2,435,681 | 625,818 |
| 2024-12-01 | 0.4286 | 6 | 14 | 240,122 | 676,666 |
| 2024-09-01 | 6.0 | 18 | 3 | 3,343,590 | 133,722 |
| 2023-09-01 | 8.0 | 8 | 1 | 360,000 | 37,062 |
| 2023-03-01 | 1.0 | 4 | 4 | 1,583,800 | 59,636 |
| 2022-06-01 | 1.6 | 8 | 5 | 23,907,364 | 82,817 |
| 2022-03-01 | 1.0 | 5 | 5 | 1,325,000 | 73,683 |
| 2021-03-01 | 1.8333 | 11 | 6 | 760,930 | 32,629 |
| 2020-09-01 | 1.3333 | 12 | 9 | 330,000 | 497,577 |
| 2020-03-01 | 0.7143 | 5 | 7 | 189,000 | 39,979 |
| 2019-12-01 | 0.2 | 1 | 5 | 6,000 | 42,039 |
| 2019-09-01 | 6.0 | 12 | 2 | 190,000 | 3,058 |
| 2019-03-01 | 0.5833 | 7 | 12 | 430,158 | 121,632 |
| 2018-09-01 | 1.2 | 12 | 10 | 122,571 | 136,110 |
| 2018-06-01 | 0.5 | 5 | 10 | 74,496 | 186,523 |
| 2018-03-01 | 0.9375 | 15 | 16 | 390,166 | 91,596 |
| 2017-12-01 | 1.5 | 3 | 2 | 424,898 | 3,000 |
| 2017-09-01 | 2.0 | 6 | 3 | 54,000 | 28,161 |
| 2017-03-01 | 11.0 | 11 | 1 | 219,000 | 433,825 |
| 2016-12-01 | 4.5 | 9 | 2 | 96,000 | 24,000 |
| 2016-09-01 | 2.5 | 5 | 2 | 302,750 | 10,000 |
| 2016-06-01 | 5.0 | 5 | 1 | 385,600 | 52,000 |
| 2015-12-01 | 0.4 | 6 | 15 | 3,571,636 | 2,796,670 |
Wave Life Notable Stakeholders
A Wave Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Wave Life often face trade-offs trying to please all of them. Wave Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Wave Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MD MBA | CEO President | Profile | |
| Chandra Vargeese | Head of Drug Discovery and Sr. VP | Profile | |
| Gregory Verdine | Founder Director | Profile | |
| Christopher Francis | Head of Bus. Devel. and VP | Profile | |
| Kate Rausch | Investor Relations | Profile | |
| Stephen Lake | VP Devel | Profile | |
| Linda JD | Senior Counsel | Profile | |
| Erik MD | Chief Officer | Profile | |
| Sridhar Vaddeboina | Manufacturing Chemistry | Profile | |
| MBA MD | CEO Pres | Profile | |
| HsiuChiung Yang | Senior Medicine | Profile | |
| Sridhar MBA | Manufacturing Chemistry | Profile | |
| Daryn Lewis | Senior Resources | Profile | |
| Kyle CFA | CFO Officer | Profile | |
| AnneMarie LiKwaiCheung | Chief Officer | Profile | |
| Jonathan Rosin | Chief Officer | Profile |
About Wave Life Management Performance
The success or failure of an entity such as Wave Life Sciences often depends on how effective the management is. Wave Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Wave management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Wave management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.26) | |
| Return On Capital Employed | (0.53) | (0.55) | |
| Return On Assets | (0.25) | (0.26) | |
| Return On Equity | (0.42) | (0.44) |
Please note, the presentation of Wave Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Wave Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Wave Life's management manipulating its earnings.
Wave Life Workforce Analysis
Traditionally, organizations such as Wave Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Wave Life within its industry.Wave Life Manpower Efficiency
Return on Wave Life Manpower
| Revenue Per Employee | 377.4K | |
| Revenue Per Executive | 6.8M | |
| Net Loss Per Employee | 338K | |
| Net Loss Per Executive | 6.1M | |
| Working Capital Per Employee | 729.8K | |
| Working Capital Per Executive | 13.1M |
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |